[1] |
Rabe K, Watz H. Chronic obstructive pulmonary disease[J]. Lancet, 2017,389:1931-1940.
|
[2] |
Dransfield M, Voelker H, Bhatt S, et al. Metoprolol for the prevention of acute exacerbations of COPD[J].N ENG L J Med, 2019,381:2304-2314.
|
[3] |
Yang R, Chang Q, Meng X, et al. Prognostic value of systemic immune-inflammation index in cancer: a Meta-analysis[J]. J Cancer, 2018,9:3295-3302.
|
[4] |
Akpinar M, Ozin Y, Kaplan M, et al. Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict mucosal disease severity in ulcerative colitis[J]. J Med Biochem, 2018,37:155-162.
|
[5] |
Kim Y, Choi H, Jung S, et al. Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-nave patients with antineutrophil cytoplasmic antibody-associated vasculitis[J]. Nephrology, 2019,24:711-717.
|
[6] |
Hurst J, Donaldson G, Perera W, et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease[J]. Am J Resp Crit Care Med, 2006,174:867-874.
|
[7] |
Sun P, Chen C, Xia Y, et al. The Ratio of C-reactive protein/albumin is a novel Inflammatory predictor of overall survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma[J]. Dis Markers, 2017,2017:657-808.
|
[8] |
Gao X, Coull B, Lin X, et al. Association of neutrophil to lymphocyte ratio with pulmonary function in a 30-year longitudinal study of US veterans[J]. JAMA Network Open, 2020,3:2010-2350.
|
[9] |
Vogelmeier C, Criner G, Martínez F, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary[J]. Arch Bronconeumol, 2017,53:128-149.
|
[10] |
Masterton R, Burley C. Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis[J]. Int J Antimicrob Age, 2001,18:503-512.
|
[11] |
Jinjuvadia C, Jinjuvadia R, Mandapakala C, et al. Trends in outcomes, financial burden, and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD) in the united states from 2002 to 2010[J]. COPD, 2017,14:72-79.
|
[12] |
Telo S, Kuluztürk M, Deveci F, et al. Serum cystatin C levels in COPD: potential diagnostic value and relation between respiratory functions[J]. J Med Biochem, 2018,37:434-440.
|